Clinical Case Discussion Forum

Subscribe to the Clinical Case Discussion Forum

× To share and enhance best practice management of CML, experts and interested clinicians can discuss difficult or interesting CML cases here. Physicians submit a brief history of the patient and the case for discussion (no more than 200 words) by posting it in this forum ("New Discussion" button below). Please include the country of origin.

Each clinical case will be forwarded to the expert clinical panel for a brief independent response. Consideration should be given to patient confidentiality. Details that are not critical to the case can be changed to preserve anonymity. Please consider including your email with the case. This will not be posted on the website, but is useful should further details be requested by the moderator.

As a full clinical history is necessary for accurate comment, cases and comments on the Forum are ONLY ACCEPTED FROM PHYSICIANS. If individual patients have a specific question we encourage them to contact their healthcare provider. General questions can be emailed to info@cml-foundation.org.

DISCLAIMER: The iCMLf does not recommend or endorse any specific tests, physicians, products, procedures, or opinions, and disclaims any representation, warranty, or guaranty as to the same. Reliance on any information provided in this Forum is solely at your own risk.

Stopping therapy after 10 years

Start
Prev
1
Next
End

Gavin Cull
Topic Author

9 years 9 months ago #1010 by Gavin Cull

Stopping therapy after 10 years was created by Gavin Cull

78 yo male with chronic phase CML diagnosed in 2005. Treated with imatinib 400mg daily since then. Considering cessation because of some side-effects (diarrhoea, anaemia). His BCR-ABL levels are as below, basically 0 for the last 2 years apart from the 0.001 level at last assessment in October 2014. Is the small blip at 0.001 of concern or is a trial of cessation still reasonable?

22/OCT/14 0.001
01/MAY/14 0.000
17/OCT/13 0.000
11/APRIL/13 0.000
25/OCT/12 0.000

DR Suresh Sanchetee
Topic Author

9 years 9 months ago #1011 by DR Suresh Sanchetee

Replied by DR Suresh Sanchetee on topic Stopping therapy after 10 years

Trial of cessation is reasonable

jeff lipton
Topic Author

9 years 9 months ago #1012 by jeff lipton

Replied by jeff lipton on topic Stopping therapy after 10 years

Cessation is a very reasonable option. Take a look at the Mahon presentation from the latest ASH on the EUROSKI study where 0.01 (MR4) was the target for stopping. Results look very good with a threshold for restarting being 0.1 or loss of MMR. If the results are valid by IS and you are able to do monthly monitoring at least for the first year and at least 2-3 monthly for the next couple, so that you can restart if necessary, go ahead. Of course, participation on a stopping study if possible is always preferred.

Tim Hughes
Topic Author

9 years 8 months ago #1014 by Tim Hughes

Replied by Tim Hughes on topic Stopping therapy after 10 years

The critical issue is that he has had 10 years of imatinib. These are the patients who are most likely to benefit from a trial of cessation. The odd very low positive signal doesn’t seem to matter much according to the French A-STIM study. However you would like to see that the positive result is not the start of a trend. I would repeat and if the level is back to zero I would go ahead with a trial of cessation. If the next PCR result is positive I would probably continue imatinib and keep watching closely and stop once you get a zero reading again – unless the need to cease based on toxicity is compelling in which case I would give it a go anyway.

Start
Prev
1
Next
End

Moderators: Nicola, arlene

Copyright © 2023 All Rights Reserved. The iCMLf is registered as charity no. 1132984 in England and Wales
Registered Address: International CML Foundation - 20 Eversley Road - Bexhill-On-Sea, East Sussex, TN40 1HE - UK